Why Lexicon Pharmaceuticals Stock Is Down Today

Why Lexicon Pharmaceuticals Stock Is Down Today

After more than doubling in value on Thursday, shares of Lexicon Pharmaceuticals (NASDAQ: LXRX) are giving up some of those gains on Friday. Second, the stock was downgraded by a Wall Street analyst. The agency thinks the results from two phase 3 clinical trials for Lexicon's sotagliflozin can support a New Drug Application (NDA).